Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · IEX Real-Time Price · USD
9.84
+0.94 (10.56%)
At close: Jul 26, 2024, 4:00 PM
9.65
-0.19 (-1.93%)
After-hours: Jul 26, 2024, 4:48 PM EDT
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $424.25 million as of July 26, 2024.
Market Cap
424.25M
Enterprise Value
52.66M
1-Year Change
n/a
Ranking
Category
Stock Price
$9.84
Market Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $424.25M, a decrease of -52.76%. That is a compound annual growth rate of -80.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 383.70M | -57.28% |
| Feb 8, 2024 | 898.10M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anika Therapeutics | 416.45M |
| AxoGen | 413.01M |
| Sight Sciences | 409.99M |
| Sonida Senior Living | 408.85M |
| Alto Neuroscience | 406.49M |
| Esperion Therapeutics | 398.78M |
| Tourmaline Bio | 396.49M |
| uniQure | 390.09M |